Day One Biopharmaceuticals, Inc. (DAWN)
8.94
-0.31
(-3.35%)
USD |
NASDAQ |
Jan 09, 16:00
8.95
+0.01
(+0.11%)
After-Hours: 20:00
Day One Biopharmaceuticals Research and Development Expense (Quarterly): 31.42M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Mersana Therapeutics, Inc. | 12.07M |
| Perspective Therapeutics, Inc. | 19.56M |
| Electromed, Inc. | 0.241M |
| InfuSystem Holdings, Inc. | -- |
| Xtant Medical Holdings, Inc. | 0.634M |